Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Monday evening:

XPO Logistics (XPO - Get Report) : "This company needs to see interest rates low but this is a speculative stock and I'm not recommending speculation right now."

GW Pharmaceuticals (GWPH) : "We've got stocks like Celgene (CELG - Get Report) and Regeneron Pharmaceuticals (REGN - Get Report) down way low. Those are better values. "

Tidewater (TDW - Get Report) : "This one just had a major move. I cannot recommend a stock after a big move like that. It needs to come in."

Fitbit (FIT - Get Report) : "I still believe in the long-term outlook for Fitbit, but I've been wrong so far."

Amicus Therapeutics (FOLD - Get Report) : "This is too speculative for me right now. "

Starwood Property Trust (STWD - Get Report) : "It yields 10% and that's a red flag for me. "

Bristol-Myers Squibb (BMY - Get Report) : "Even at $66 I remain a solid buyer."

Main Street Capital (MAIN - Get Report) : "We don't really know what they own. You'll have to own this one without me."

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

 

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.